Skip to main content

Advertisement

Log in

Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism

  • Case Report
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Hypomagnesemia is a common but often overlooked problem in hospitalized patients. Unrecognized hypomagnesemia can cause serious complications. The association of hypokalemia and hypocalcemia is strongly evocative of a magnesium deficiency. Research into the causes of hypomagnesemia is imperative, as it will definitely change the approach, treatment and prognosis. We report the case of a 65-year-old man with chronic hypocalcemia and hypokalemia associated with cerebellar syndrome, a solitary seizure and cerebellar hyperintensities on magnetic resonance imaging. After the detection and treatment of hypomagnesemia with oral supplements of magnesium and the replacement of pantoprazole with ranitidine, we observed immediate relief of the symptoms. In conclusion, in clinical practice, magnesium depletion should be investigated in elderly patients with hypocalcemia treated with proton pump inhibitors for many years, in particular in the presence of neurological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Wong ET, Rude RK, Singer FR, Shaw ST Jr (1983) A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 79(3):348–352

    Article  CAS  PubMed  Google Scholar 

  2. de Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95(1):1–46

    Article  PubMed  Google Scholar 

  3. Shah GM, Kirschenbaum MA (1991) Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab 17(1):58–64

    CAS  PubMed  Google Scholar 

  4. Rapisarda F, Portale G, Ferrario S, Sessa C, Aliotta R, Zanoli L, Fatuzzo P (2016) Magnesium, calcium and potassium: “no one was born alone”. G Ital Nefrol 33(1):1–5

  5. Nijenhuis T, Hoenderop JG, Bindels RJ (2004) Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 15(3):549–557

    Article  CAS  PubMed  Google Scholar 

  6. Freitag JJ, Martin KJ, Conrades MB, Bellorin-Font E, Teitelbaum S, Klahr S, Slatopolsky E (1979) Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest 64(5):1238–1244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chase LR, Slatopolsky E (1974) Secretion and metabolic efficacy of parthyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab 38(3):363–371

    Article  CAS  PubMed  Google Scholar 

  8. Yang L, Frindt G, Palmer LG (2010) Magnesium modulates ROMK channel-mediated potassium secretion. J Am Soc Nephrol 21(12):2109–2116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Huang CL, Kuo E (2007) Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 18(10):2649–2652

    Article  PubMed  Google Scholar 

  10. Bilezikian JP, Khan A, Potts JT Jr et al (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26(10):2317–2337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T (2011) Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone. J Bone Miner Metab 29(6):752–755

    Article  PubMed  Google Scholar 

  12. Perazella MA (2013) Proton pump inhibitors and hypomagnesemia: a rare but serious complication. Kidney Int 83(4):553–556

    Article  CAS  PubMed  Google Scholar 

  13. Epstein M, McGrath S, Law F (2006) Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 355(17):1834–1836

    Article  CAS  PubMed  Google Scholar 

  14. Ayuk J, Gittoes NJ (2014) Treatment of hypomagnesemia. Am J Kidney Dis 63(4):691–695

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Granata.

Ethics declarations

Conflict of interest

None.

Ethical approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

The subject included in this case report furnished written informed consent.

Additional information

P. Fatuzzo, L. Zanoli and A. Granata have contributed equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fatuzzo, P., Portale, G., Scollo, V. et al. Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism. J Nephrol 30, 297–301 (2017). https://doi.org/10.1007/s40620-016-0319-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-016-0319-0

Keywords

Navigation